Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 19];2(S1):S53. Available from: https://skin.dermsquared.com/skin/article/view/299